首页> 外文期刊>International immunopharmacology >Breast cancer: Biology, biomarkers, and treatments
【24h】

Breast cancer: Biology, biomarkers, and treatments

机译:乳腺癌:生物学,生物标志物和治疗方法

获取原文
获取原文并翻译 | 示例
           

摘要

During the past recent years, various therapies emerged in the era of breast cancer. Breast cancer is a heterogeneous disease in which genetic and environmental factors are involved. Breast cancer stem cells (BCSCs) are the main player in the aggressiveness of different tumors and also, these cells are the main challenge in cancer treatment. Moreover, the major obstacle to achieve an effective treatment is resistance to therapies. There are various types of treatment for breast cancer (BC) patients. Therefore, in this review, we present the current treatments, novel approaches such as antibody-drug conjugation systems (ADCs), nanoparticles (albumin-, metal-, lipid-, polymer-, micelle-based nanoparticles), and BCSCs-based therapies. Furthermore, prognostic and predictive biomarkers will be discussed also biomarkers that have been applied by some tests such as Oncotype DX, Mamm aPrint, and uPA/PAI-1 are regarded as suitable prognostic and predictive factors in breast cancer.
机译:在过去的近年来,乳腺癌时代出现了各种疗法。 乳腺癌是一种异质疾病,其中涉及遗传和环境因素。 乳腺癌干细胞(BCSCs)是不同肿瘤侵蚀性的主要球员,也是这些细胞是癌症治疗中的主要挑战。 此外,实现有效处理的主要障碍是对疗法的抵抗力。 乳腺癌(BC)患者有各种类型的治疗方法。 因此,在本次综述中,我们介绍了当前的处理,新方法,如抗体 - 药物缀合系统(ADC),纳米颗粒(白蛋白,金属,脂质,聚合物,胶束基纳米粒子)和基于BCSC的疗法等 。 此外,将讨论预后和预测生物标志物也将被诸如Onootype DX,MAMM APLint等一些测试应用的生物标志物被认为是乳腺癌中适当的预后和预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号